James Hurley

Title: Innovations by James Hurley in Bladder Cancer Detection

Introduction

James Hurley is an accomplished inventor based in Marblehead, MA (US), known for his significant contributions to medical diagnostics. With a total of three patents to his name, he has focused on developing innovative methods for detecting and treating serious health conditions.

Latest Patents

Hurley's latest patents include groundbreaking methods for developing urine biomarkers and detecting bladder cancer. The first patent relates to methods for detecting and treating bladder cancer in a subject using gene expression level measurements from exosomes derived from the subject. This innovative approach aims to improve early detection and treatment options for patients. His second patent focuses on methods of detecting renal transplant rejection using microvesicle nucleic acid biomarkers. This invention utilizes microvesicle biomarkers, including nucleic acid signatures and proteins, to assess and monitor kidney transplant rejection in patients.

Career Highlights

Throughout his career, James Hurley has worked with notable organizations such as Exosome Diagnostics, Inc. and Brigham and Women's Hospital. His work in these institutions has allowed him to collaborate on cutting-edge research and contribute to advancements in medical technology.

Collaborations

Some of his notable coworkers include Robert Kitchen and Vasisht Tadigotla, who have collaborated with him on various projects related to his patents.

Conclusion

James Hurley's innovative work in the field of medical diagnostics, particularly in bladder cancer detection and renal transplant rejection, showcases his commitment to improving patient outcomes through technology. His contributions continue to influence the medical community and pave the way for future advancements.